510(k) device
EchoNext
Pathwai, Inc. · Cardiovascular Machine Learning-Based Notification Software (QXO, Class II) · First FDA decision Jun 8, 2026, newest Jun 8, 2026Heart failure
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
2
Naming "EchoNext"
MAUDE reports
0
Brand "EchoNext", since 2015
PubMed studies
13
Mentioning "EchoNext"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- EchoNextBreakthrough510(k)
K260332 · Decided Jun 8, 2026 · 126 days after receipt
Device type: Cardiovascular Machine Learning-Based Notification Software (QXO) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "EchoNext", any status and sponsor, newest update first.
- Capitalizing on AI to CapTure Undiagnosed Structural Heart DiseasePivotal-lookingActive, not recruiting
Pierre EliasAcademic, hospital or other
NCT07843004 · 4,000 participants (planned) · Start Sep 16, 2026 · Primary completion Jun 1, 2027
Device: EHR Alert · For: Structural Heart Abnormality; Valve Heart Disease; Heart Diseases and 1 more
Sites: New York, New York
- Deployment and Evaluation of Artificial Intelligence Software for Electrocardiogram Analysis and Management in Primary CarePivotal-lookingEnrolling by invitation
Montreal Heart InstituteAcademic, hospital or other
NCT06637293 · 2,000 participants (planned) · Start Oct 2, 2025 · Primary completion Jan 2027
Device: DeepECG plateform diagnosis & recommendations · For: Primary Care Provider; Structural Heart Disease
Sites: Montreal, Canada
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "EchoNext", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QXO
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "EchoNext"[tiab]. The summary above synthesizes these.
- Detecting structural heart disease from electrocardiograms using AI.
Poterucha TJ, Jing L, Ricart RP, et al. · Nature · 2025Research Support, N.I.H., Extramural
- Artificial Intelligence-Enabled Electrocardiographic Detection of Severe Aortic Stenosis Leading to Transcatheter Aortic Valve Replacement.
Tat E, Oliver FR, Malta P, et al. · JACC Case Rep · 2026Case Reports
- Uncertainty-aware classification and triage of structural heart disease using electrocardiography and echocardiography metrics.
Colebank MJ · ArXiv · 2026Preprint
- Agentic Autodiscovery of Diastolic Dysfunction Phenotypes from Surface Electrocardiogram.
Jamthikar AD, Shanmugham A, Singh S, et al. · medRxiv · 2026Preprint
- Artificial intelligence electrocardiography for left ventricular systolic dysfunction demonstrates preserved performance across demographic training imbalances.
Hsieh PN, Agrawal P, Alok A, et al. · Eur Heart J Digit Health · 2026
- EchoNext-Mini: A Dataset and Baseline AI Model for Detecting Structural Heart Disease from Electrocardiograms.
Hughes JW, Jing L, Finer J, et al. · NEJM AI · 2026
- The ECG-echocardiography interval in EchoNext-Mini validation.
Isleyen HB, Bulut S · Eur Heart J Digit Health · 2026Letter
- Transportability of an artificial intelligence electrocardiography model for structural heart disease: external validation and recalibration of EchoNext-Mini in MIMIC-IV.
Otabor E, Hassan A, Okunlola A, et al. · Eur Heart J Digit Health · 2026
- Association of Valvular Disease Progression Using Echocardiographic Findings in a Large U.S. Cohort.
Bautista Neughebauer AA, Yehya A, Benza RL, et al. · Echocardiography · 2026
- Cumulative electrocardiogram abnormalities predict left ventricular ejection fraction reduction: EchoNext database analysis.
Kim S, Saad B, Chu G · J Electrocardiol · 2026
- Quantifying and disentangling sources of QRS duration and QTc interval divergence between Korean (SNUH) and US (EchoNext) wide QRS cohorts.
Lee C · J Electrocardiol · 2026
- AI-ECG Detection of Structural Heart Disease in the Community Setting: Transportability and Spectrum Effects in the PREVUE-VALVE Study.
Poterucha TJ, Hughes JW, Brener MI, et al. · J Am Coll Cardiol · 2026Multicenter Study
Other devices of this type
Also filed under product code QXO.
- Viz HCMViz. Ai, Inc. · De Novo 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.